Receptor Tyrosine Kinases (RTKs) in Breast Cancer: Signaling, Therapeutic Implications and Challenges

Molecular Cancer - United Kingdom
doi 10.1186/s12943-018-0797-x
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Springer Science and Business Media LLC

Related search

Tyrosine Kinase Signalling in Breast Cancer: ErbB Family Receptor Tyrosine Kinases

Breast Cancer Research
Cancer ResearchOncology
2000English

Interplay Between Receptor Tyrosine Kinases and Hypoxia Signaling in Cancer

International Journal of Biochemistry and Cell Biology
BiochemistryCell Biology
2015English

Signaling by Receptor Tyrosine Kinases

Annual Review of Biochemistry
Biochemistry
1993English

Receptor Tyrosine Kinases Endocytosis in Endothelium: Biology and Signaling

Arteriosclerosis, Thrombosis, and Vascular Biology
Cardiovascular MedicineCardiology
2014English

Receptor Tyrosine Kinases and Inhibitors in Lung Cancer

The Scientific World Journal
BiochemistryMedicineGeneticsMolecular BiologyEnvironmental Science
2004English

Ibrutinib Inhibits ERBB Receptor Tyrosine Kinases and HER2-Amplified Breast Cancer Cell Growth

Molecular Cancer Therapeutics
Cancer ResearchOncology
2016English

Exploring Receptor Tyrosine Kinases-Inhibitors in Cancer Treatments

Egyptian Journal of Medical Human Genetics
Genetics
2019English

Drug-Induced Ubiquitylation and Degradation of ErbB Receptor Tyrosine Kinases: Implications for Cancer Therapy

EMBO Journal
ImmunologyMolecular BiologyBiochemistryMicrobiology NeuroscienceMedicineGenetics
2002English

Erratum To: Differential Expression of Receptor Tyrosine Kinases (RTKs) and IGF-I Pathway Activation in Human Uterine Leiomyomas

Molecular Medicine
Molecular MedicineGeneticsMolecular Biology
2008English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2025 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy